Multiple putative targets via aloe components

Multiple putative targets via aloe components refers to the collective pharmacological profile of various bioactive molecules found in the Aloe vera plant, rather than a single discrete therapeutic target. Key constituents include anthraquinones such as aloin and aloe-emodin, which have been shown to target enzymes like Casein kinase II (CK2) and Topoisomerase II, thereby modulating cell cycle progression and inducing apoptosis in various cell lines (PMID: 11434300, 17611931). Additionally, the complex polysaccharide acemannan is known to interact with immune cell receptors, such as Toll-like receptor 4 (TLR4), to stimulate macrophage activation and the release of cytokines (PMID: 25233617). These diverse interactions support the plant's traditional use in treating inflammation, promoting wound healing, and serving as a potent laxative. However, the lack of a singular target and the presence of multiple active compounds complicate its clinical application. Safety concerns are significant, particularly regarding the long-term ingestion of anthraquinones, which are associated with potential carcinogenicity, hepatotoxicity, and severe electrolyte imbalances (NIH/NCCIH).

Other names

Aloe vera bioactive targetsPhytochemical targets of AloeAloe vera extract targets

Bioactive components of Aloe vera interact with multiple targets: anthraquinones like emodin inhibit Casein kinase II (CK2) and Topoisomerase II (PMID: 11434300, 17611931); polysaccharides like acemannan activate macrophages potentially via Toll-like receptor 4 (TLR4) (PMID: 25233617); and aloin promotes chloride secretion in the colon to exert laxative effects.